Dipeptidyl peptidase-4 inhibitors in type 2 diabetes therapy – focus on alogliptin

Type 2 diabetes mellitus is a complex and progressive disease that is showing an apparently unstoppable increase worldwide. Although there is general agreement on the first-line use of metformin in most patients with type 2 diabetes, the ideal drug sequence after metformin failure is an area of incr...

Full description

Saved in:
Bibliographic Details
Main Authors: Capuano, Annalisa, Sportiello, Liberata, Maiorino, Maria Ida, Rossi, Francesco, Giugliano, Dario, Esposito, Katherine
Format: Artigo
Language:Inglês
Published: Dove Medical Press 2013
Subjects:
Review
Online Access:https://ncbi.nlm.nih.gov/pmc/articles/PMC3782406/
https://ncbi.nlm.nih.gov/pubmed/24068868
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/DDDT.S37647
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items